|
2639
|
AMG 232
|
Potent, selective, and orally bioavailable MDM2-p53 inhibitor |
€115.00
|
|
1643
|
HLI 373
|
HDM2 inhibitor |
€95.00
|
|
1538
|
JNJ 26854165
|
HDM2 inhibitor |
€105.00
|
|
1586
|
JNJ 26854165 dihydrochloride
|
HDM2 inhibitor |
€105.00
|
|
2565
|
N106
|
Activator of E1 ligase mediated SERCA2a SUMOylation |
€95.00
|
|
1585
|
Nutlin-3
|
MDM2 inhibitor (p53 specific) |
€95.00
|
|
1880
|
Nutlin-3a
|
Inhibitor of MDM2 |
€95.00
|
|
1881
|
Nutlin-3b
|
Less potent (+)-enantiomer of Nutlin-3 |
€90.00
|
|
1953
|
PRT 4165
|
E3 Ubiquitin ligase Bmi1/Ring1A inhibitor |
€70.00
|
|
2009
|
RITA
|
Activates p53 through inhibition of MDM2 |
€105.00
|
|
2741
|
SAR405838
|
MDM2-p53 inhibitor |
€125.00
|
|
2164
|
SJ 172550
|
Small molecule inhibitor of MDMX |
€95.00
|
|
1904
|
SMER 3
|
Inhibitor of an SCF family E3 Ubiquitin ligase |
€90.00
|
|
2426
|
SMURF1 inhibitor A01
|
Inhibitor of E3 ubiquitin-protein ligase SMURF1 |
€115.00
|
|
2437
|
SP 141
|
Specific MDM2 inhibitor with therapeutic effects in breast cancer models |
€120.00
|